REPL - Replimune Group, Inc.
IEX Last Trade
12.415
-0.345 -2.779%
Share volume: 0
Last Updated: Fri 27 Dec 2024 03:30:24 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.51%
PREVIOUS CLOSE
CHG
CHG%
$12.76
-0.35
-2.70%
View ratios
| Fiscal Date | |
|---|---|
| Fiscal Quarter | |
| Report Date | |
| Total revenue | |
| Cost of revenue | |
| Gross profit | |
| Operating expenses | |
| Selling general and admin | |
| Research and development | |
| Total expenses | |
| Operating income | |
| Ebit | |
| Pretax income | |
| Income tax | |
| Net income basic | |
| Net income |